Your browser doesn't support javascript.
loading
Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis.
Dichiara, Maria; Simpson, Quillon J; Quotadamo, Antonio; Jalani, Hitesh B; Huang, Anson X; Millard, Caroline C; Klug, Dana M; Tse, Edwin G; Todd, Matthew H; Silva, Daniel Gedder; da Silva Emery, Flavio; Carlson, J Eric; Zheng, Shao-Liang; Vleminckx, Margot; Matheeussen, An; Caljon, Guy; Pollastri, Michael P; Sjö, Peter; Perry, Benjamin; Ferrins, Lori.
  • Dichiara M; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Simpson QJ; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Quotadamo A; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Jalani HB; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Huang AX; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Millard CC; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Klug DM; School of Pharmacy, University College London, London WC1N 1AX, U.K.
  • Tse EG; School of Pharmacy, University College London, London WC1N 1AX, U.K.
  • Todd MH; School of Pharmacy, University College London, London WC1N 1AX, U.K.
  • Silva DG; School of Pharmacy, University College London, London WC1N 1AX, U.K.
  • da Silva Emery F; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040-903, Brazil.
  • Carlson JE; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040-903, Brazil.
  • Zheng SL; Rilas Technologies, Inc, 150-W New Boston Street, Woburn, Massachusetts 01801, United States.
  • Vleminckx M; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.
  • Matheeussen A; Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.
  • Caljon G; Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.
  • Pollastri MP; Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.
  • Sjö P; Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Perry B; Drugs for Neglected Diseases Initiative, 15 Chemin Camille Vidart, Geneva 1202, Switzerland.
  • Ferrins L; Drugs for Neglected Diseases Initiative, 15 Chemin Camille Vidart, Geneva 1202, Switzerland.
ACS Infect Dis ; 9(8): 1470-1487, 2023 08 11.
Article en En | MEDLINE | ID: mdl-37417544
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leishmaniasis / Leishmania / Leishmaniasis Visceral Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leishmaniasis / Leishmania / Leishmaniasis Visceral Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article